86 results on '"Milosevic, Michael"'
Search Results
2. Targeting the CXCL12/CXCR4 pathway to reduce radiation treatment side effects
3. Repeatability and reproducibility of MRI-based radiomic features in cervical cancer
4. Vulnerabilities of radiomic signature development: The need for safeguards
5. 109 Clinical Validation of HPV CTDNA for Early Detection of Residual Disease Following Chemoradiation in Cervical Cancer
6. 707: Expanding access to computed tomographic staging and three dimensional RT for cervical cancer
7. 338: Intra-operative process efficiency for in-room MR-guided brachytherapy for cervical cancer
8. Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study
9. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer
10. Planned versus ‘delivered’ bladder dose reconstructed using solid and hollow organ models during prostate cancer IMRT
11. 53: Comparing Dosimetry of Locally Advanced Cervix Cancer Patients Treated with 3 Versus 4 Fractions of MRI-Guided Brachytherapy
12. Hybrid adaptive radiotherapy with on-line MRI in cervix cancer IMRT
13. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer
14. 794: Clinical outcomes of 3 vs 4 Fractions of MRI-guided brachytherapy in cervical cancer
15. Patient-specific PTV margins in radiotherapy for bladder cancer – A feasibility study using cone beam CT
16. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study
17. Radiosurgery scope of practice in Canada: A report of the Canadian association of radiation oncology (CARO) radiosurgery advisory committee
18. The relationship between external beam radiotherapy dose and chronic urinary dysfunction – A methodological critique
19. 4: Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial
20. 145: Access to Radiotherapy in Ghana: A Geospatial Analysis
21. 87: Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients
22. A randomized comparison of interfraction and intrafraction prostate motion with and without abdominal compression
23. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer
24. Management of gynecologic cancer: Choosing radiotherapy wisely by 3 Southern Ontario academic centers during the COVID-19 pandemic
25. 17: A Prognostic Gene Expression Signature for Women with Cervical Cancer Receiving Curative Intent Treatment
26. 58: Patterns of Practice and Clinical Outcomes in Patients with Vulvar Carcinoma
27. 186: A Pan-Canadian Approach to Patient-Centered Quality Improvement Initiatives: Development and Promotion of Patient Education, Engagement and Patient Reported Outcome Guidance Documents
28. 144: A Pan-Canadian Approach to Supporting The Collection and Utilization of Patient Reported Outcomes in Radiation Oncology: An Initiative of the Canadian Partnership for Quality Radiotherapy
29. A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy
30. Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy
31. 81 Dose Reconstruction of Cervical Cancer Adaptive Radiotherapy Delivered with Hybrid CBCT-MRI Guidance
32. 212 Patient Reported Outcomes Used in Radiation Programs Across Canada
33. 58 Targeting Aurora Kinase to Enhance the Curative Potential of Radiotherapy in HPV Related Cancers
34. 162 Clinical Implementation of an Integrated Mr-Guided Linear Accelerator for Offline Adaptive Radiotherapy for Cervical Cancer
35. 241 Response and Intervention to Elevated ESAS Scores: A Chart Audit of Gynecologic Oncology Clinics
36. 191 Clinical Outcomes of Surgically Unresectable Endometrial Cancers
37. 11: Global Access to Radiotherapy for Cervical Cancer: The Cost of Inaction
38. 146: Current Practice of External Beam Radiotherapy and Brachytherapy for Management of Endometrial Cancer in Ontario, Canada
39. 107: CARO-Elekta Fellowship Prospective Study of Dynamic Contrast-Enhanced MRI, Diffusion-Weighted MRI, and FDG PET Imaging in Brachytherapy for Cervix Cancer
40. 176: Measuring Uptake of the Canadian Partnership for Quality Radiotherapy (CPQR) Programmatic Key Quality Indicators (KQI): A Pan-Canadian Audit of Compliance
41. 113: Models of Care for Cervical Cancer Brachytherapy in Ontario
42. 82: Planned Versus ‘Delivered’ Bladder Dose Reconstructed using Solid and Hollow Organ Models During Prostate Cancer IMRT
43. 14: Current Practice of Brachytherapy and External Beam Radiotherapy for Cervical Cancer in Ontario, Canada
44. Managing a national radiation oncologist workforce: A workforce planning model
45. The effect of delineation method and observer variability on bladder dose-volume histograms for prostate intensity modulated radiotherapy
46. 129 HIGH INTERSTITIAL FLUID PRESSURE (IFP) AND HYPOXIA ARE BIOMARKERS OF CISPLATIN CHEMO-RADIATION RESPONSE IN ADVANCED CERVIX CANCER
47. A phase II study of localized prostate cancer treated to 75.6Gy with 3D conformal radiotherapy
48. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer
49. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer
50. RESPONSE TO WIECEL AND HINKELBEIN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.